Loading...
Guest User
Welcome! Please login.
| IPO Listing At | BSE SME |
| SME IPO Issue Type | Book Build Issue |
| Total Issue Size | ₹12.61 Cr |
| Reserved for Market Maker | ₹0.00 Cr |
| Net Issue Size | ₹12.61 Cr |
| Fresh Issue | ₹11.95 Cr |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹52.00-55.00 per share |
| Discount | Retail: 0.00 |
| BSE Code | 544169 |
| Registrar | Bigshare Services Pvt.Ltd. |
| Lead Managers | Hem Securities Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 2,000 shares and in multiples thereof
Incorporated in October 2007, Amkay Products Limited is a company that produces and sells a wide range of healthcare products including medical devices, disposables, and other essential items such as face masks, alcohol swabs, lancet needles, nebulizers, pulse oximeters, surgeon caps, and more. Their products are used by healthcare centers, hospitals/clinics, nursing homes, and other such facilities across India.
The company manufactures and markets products such as diapers, plastic gloves, and suction machines.
The company offers over 30 healthcare products, including medical devices for respiratory diseases, surgical disposables, home healthcare products, and others. We manufacture 20 products and brand/trade 10 others.
The manufacturing facility, which occupies an area of about 26000 sq. ft., is fully equipped with machines, a testing lab, and other handling equipment to ensure a smooth process. The company is also accredited under the ISO 9001:2015 standard by QRO Certification LLP for its quality management system.
The company has two manufacturing unit situated in Thane, Maharashtra and a Wearhouse situated in Thane Maharastra.
As of December 31, 2023, the company has employed about 75 employees across different levels of the organization.
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding Capital Expenditure towards installation of additional Machinery | 0.50 |
| 2 | To meet working capital requirements | 8.00 |
| 3 | General Corporate Purpose | 2.59 |
| Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 18.88 | 15.64 | 15.81 | 13.93 |
| Total Income | 23.86 | 28.25 | 36.79 | 40.72 |
| Profit After Tax | 2.15 | 1.51 | 1.47 | 3.13 |
| NET Worth | 9.87 | 7.72 | 6.21 | 4.74 |
| Reserves and Surplus | 3.51 | 7.44 | 5.93 | 4.46 |
| Total Borrowing | 4.76 | 4.70 | 4.34 | 1.37 |
| Amount in ₹ Crore | ||||
| KPI | Dec 31, 2024 |
|---|---|
| ROE | 24.49% |
| ROCE | 21.54% |
| Debt / Equity | 0.48% |
| RoNW | 21.82% |
| PAT Margin | 9.47% |
| Price to Book Value | 3.55 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 2.37 | 3.32 |
| P/E (x) | 23.18 | 16.58 |
| Promoter Holding | 99.89% | 73.44% |
| Market Cap | ₹47.61 Cr. | |
